| Patents for C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111) |
|---|
| 10/29/2003 | CN1452629A Skin tissue regeneration prmoters comprising ginsenoside Rb1 |
| 10/29/2003 | CN1452628A 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds |
| 10/23/2003 | US20030199485 Novel anti-inflammatory androstane derivative |
| 10/15/2003 | EP1351973A1 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 10/07/2003 | US6630453 Androgen derivatives and uses thereof |
| 09/25/2003 | US20030181396 Novel oligospirostanoside, pharmaceutical composition containing novel oligospirostanoside and method for immunomodulation using said oligospirostanoside |
| 09/25/2003 | US20030181395 Process for the isolation of novel oligospirostanoside |
| 09/24/2003 | CN1122042C Process for preparing rare sinsenoside |
| 09/18/2003 | WO2003075931A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |
| 09/18/2003 | CA2478931A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |
| 09/16/2003 | US6620801 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 09/16/2003 | CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 09/10/2003 | EP1341801A2 A process for isolating saponins from soybean-derived materials |
| 09/03/2003 | CN1439673A High friction coefficient rubber composite brake shoes |
| 09/03/2003 | CN1439375A 脱氢表雄酮的治疗用途和传送系统 DHEA therapeutic uses and delivery systems |
| 09/03/2003 | CN1120171C Medicinal use of total sterone in radix rhapontici and preparing method thereof |
| 08/28/2003 | WO2003062259A3 Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents |
| 08/28/2003 | US20030162701 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 08/27/2003 | CN1439018A 9alpha-chloro-6alpha-fluoro-17alpha-hydroxy-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl group |
| 08/21/2003 | US20030158163 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds |
| 08/20/2003 | CN1437610A Oxidation process for preparing the intermediate 6alpha, 9alpha-difluoro-11beta, 17alpha-dihydroxy-16.alpha-methyl-androst-1, 4-dien-3-one-17.Beta-carboxylic acid |
| 08/14/2003 | WO2003066656A1 Crystalline complexes of fluticasone 2-furoate |
| 08/14/2003 | WO2003066655A1 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form |
| 08/14/2003 | WO2003066036A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor for the treatment of inflammatory and allergic conditions |
| 08/14/2003 | WO2003066032A1 Formulations for inhalation |
| 08/14/2003 | WO2003066026A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier |
| 08/14/2003 | WO2003066024A1 Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions |
| 08/14/2003 | US20030153542 Novel anti-inflammatory androstane derivative compositions |
| 08/07/2003 | WO2003064445A1 17-alpha-heterocyclic esters of androstane derivatives having anti-inflammatory activity |
| 08/07/2003 | US20030148962 For therapy of ischemic cerebral-vascular diseases |
| 08/07/2003 | US20030148279 Nucleic acid probe unique to methanogenic bacteria; detection of methanogenic bacteria has use such as to stimulate production of methane from unrecoverable petroleum crude oils in hydrocarbon formations |
| 08/05/2003 | CA2362917C Methods for anti-tumor therapy |
| 07/31/2003 | WO2003062259A2 Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents |
| 07/31/2003 | WO2003035668A3 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 07/31/2003 | US20030144257 Administering to a human or animal for inflammation/allergies 6-alpha-9-alpha-difluoro-17 alpha-(2-furanylcarbonyl)oxy)-11 beta-hydroxy-16-alpha-methyl-3-oxo-androsta-1,4-diene-17 beta-carbothioic acid-s-fluoromethyl ester |
| 07/30/2003 | EP1135403B1 17beta-acyl-17alpha-propynyl-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/15/2003 | US6593301 Ligosaccharide glycosides derived from spirostane with high effective and low side action wherein the dementia is Alzheimer's disease, vascular dementia, or mixed type dementia |
| 07/15/2003 | CA2223234C A process for the preparation of metabolites of ginseng saponins |
| 07/15/2003 | CA2086221C Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agent |
| 07/10/2003 | WO2002038166A3 Ginseng berry extracts and pharmaceutical compositions therefrom |
| 06/17/2003 | US6579853 For inhibiting apoptosis or apoptosis-like cell death |
| 06/12/2003 | US20030109511 Novel anti-inflammatory androstane derivative compositions |
| 06/05/2003 | US20030104079 Prevention, treatment or therapy of organic diseases causing histopathological changes of the vital or viable tissues; wound healing promoters; plant and animal growth regulators |
| 06/04/2003 | EP0973790B1 Estra-5(10),7-dienes with estrogenic activity |
| 06/03/2003 | CA2332652C .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors |
| 05/30/2003 | WO2003043640A2 Treatment of major depressive disorder using glucocorticoid receptor antagonists |
| 05/15/2003 | US20030092690 Administering by inhalation |
| 05/14/2003 | CN1417224A Ginsenoside acid hydrolyzing process of preparing protopanoxadiol |
| 05/08/2003 | US20030087836 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 05/08/2003 | US20030087835 Novel aglycon dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 05/08/2003 | US20030086984 Treating collected plant material with a solvent to extract a fraction having appetite suppressant activity, separating extraction solution from plant material, removing the solvent from extraction solution and recovering |
| 05/02/2003 | EP1305330A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
| 05/02/2003 | EP1305329A1 6.alpha.,9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl)oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 05/02/2003 | EP0811006B1 Benzopyran-containing compounds and method for their use |
| 05/01/2003 | WO2003035668A2 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 05/01/2003 | US20030083231 Used of androstane derivatives in treatment of conditions such as thrombocytopenia, neutropenia or the delayed effects of radiation therapy |
| 04/30/2003 | CN1414010A Cardiac glycoside type compound for treating carcinosis and its preparation method |
| 04/30/2003 | CN1414009A Method for extracting and separating notoginsenoside R1, panaxcoside Re, pseudo-ginseng element from pseudo-ginseng crude powder |
| 04/24/2003 | WO2002079219A3 Anti-proliferative 6-o-acyl-beta-d-glucosyl-beta-sitosterol compounds |
| 04/23/2003 | EP1304333A2 6,7-Oxygenated steroids and uses related thereto |
| 04/17/2003 | US20030073676 Dissolving in aqueous carrier; antiallergens |
| 04/16/2003 | EP1301526A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 04/16/2003 | CN1411466A Compound (I), method for extracting it and pharmaceutical composition containing it |
| 04/10/2003 | WO2002055529A8 A process for isolating saponins from soybean-derived materials |
| 04/09/2003 | EP1299409A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 04/09/2003 | CN1409724A 雌二醇轭合物和其用途 Estradiol conjugates and uses thereof |
| 03/27/2003 | US20030060425 Immune modulation method using steroid compounds |
| 03/26/2003 | EP1295893A1 SKIN TISSUE REGENERATION PROMOTERS COMPRISING GINSENOSIDE Rb1 |
| 03/25/2003 | US6537983 Anti-inflammatory androstane derivatives |
| 03/20/2003 | WO2003022866A1 LIGAND FOR ß2-GLYCOPROTEIN I AND USE THEREOF |
| 03/11/2003 | CA2099543C Photochemical labelling of nucleic acids with digoxigenin reagents and their use in gene probe test systems |
| 03/06/2003 | US20030045512 Androstanecarbothioic acid derivatives, especially esterified with thazol-5-ylcarboxylic acid; formulation for administration by inhalation |
| 03/05/2003 | EP1288220A2 Neuroactive 3.alpha.-hydroxy-steroids of the androstane and pregnane series |
| 03/05/2003 | EP1140972B1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 03/03/2003 | WO2002019971A1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 02/25/2003 | CA2078804C Manufacture and use of novel glycosides of catechol estrogens |
| 02/20/2003 | WO2002055529A3 A process for isolating saponins from soybean-derived materials |
| 02/12/2003 | EP0863906B1 Heterocyclic dioxethane substrates, process for their preparation and their use |
| 02/06/2003 | WO2003010182A1 Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 02/05/2003 | EP1280816A1 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them |
| 02/05/2003 | CN1100541C Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 01/15/2003 | EP0595796B1 Method of treatment of androgen-related diseases |
| 01/09/2003 | US20030008853 Administering 22,29-epoxy-3,4,6,7,29-pentahydroxy-,(3 alpha ,4 beta ,5 alpha , 6 alpha ,7 beta ,14 beta ,22S)-stigmastan-15-one and carrier for wetting eye |
| 01/02/2003 | EP0980382B1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 12/19/2002 | WO2002100879A1 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| 12/04/2002 | EP0917534B1 6,7-oxygenated steroids and uses related thereto |
| 11/28/2002 | WO2002094284A1 Method of treating dry eye disorders |
| 11/28/2002 | US20020177581 Novel anti-inflammatory androstane derivative |
| 11/28/2002 | US20020177150 Nucleoside composition for use as tool in human therapeutics and diagnositcs |
| 11/28/2002 | CA2447918A1 Method of treating dry eye disorders |
| 11/21/2002 | WO2001042273A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 11/21/2002 | US20020173496 Formulation containing novel anti-inflammatory androstane derivative |
| 11/14/2002 | US20020168427 Plant extract |
| 11/07/2002 | US20020165211 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler |
| 10/24/2002 | US20020156051 Atherosclerosis and hyperlipidemia; ascorbic acid and anticholesterol agents that are 3-hydroxy-3-methyl glutaryl coenzyme-A reductase inhibitors |
| 10/10/2002 | WO2002079219A2 Anti-proliferative 6-o-acyl-beta-d-glucosyl-beta-sitosterol compounds |
| 10/09/2002 | CN1092204C Semisynthesizing method for 20(S)-ginsenoside Rg3, and use thereof in medicine |
| 10/09/2002 | CN1092203C Process for extracting ginsenoside Re, and use of medicine thereof |
| 09/26/2002 | US20020136785 Screening for the active compound of Panax plant berries, which may be a ginsenoside |
| 09/25/2002 | CN1370781A 1-testosterone tetrahydropyrane ether and it sprepn |